Literature DB >> 9164952

Oral immunization with simian immunodeficiency virus p55gag and cholera toxin elicits both mucosal IgA and systemic IgG immune responses in nonhuman primates.

M Kubota1, C J Miller, K Imaoka, S Kawabata, K Fujihashi, J R McGhee, H Kiyono.   

Abstract

Rhesus macaques were orally immunized with a mucosal vaccine consisting of two different concentrations (1 mg vs 250 microg) of recombinant SIV p55gag (p55) with or without cholera toxin (CT, 50 microg) as a mucosal adjuvant. The plasma from macaques receiving the higher dose of p55 (1 mg) and CT had higher p55-specific IgG and IgA Ab titers compared with macaques that received the lower dose of p55 (250 microg) and CT. Further, high levels of p55-specific IgG and IgA Abs were present in external secretions from both groups. The level of p55-induced T cell responses was elevated in PBMCs isolated from the high dose group compared with the low dose group. When culture supernatants from these p55-stimulated PBMCs were examined for Th1 (IFN-gamma) and Th2 (IL-4 and IL-10) cytokines, both IFN-gamma and IL-10 were present, but IL-4 was absent. CD4+ T cells isolated from these p55-stimulated PBMCs contained IFN-gamma spot-forming cells (SFCs) but not IL-4 SFCs. These results were further confirmed by cytokine-specific reverse transcriptase PCR analysis, where p55-specific CD4+ T cells expressed mRNA for IFN-gamma, IL-6, and IL-10, but not IL-4. These findings suggest that oral immunization of nonhuman primates induced both IFN-gamma-secreting Th1 and select Th2 cytokine (e.g., IL-6 and IL-10)-producing CD4+ Th cells, which accounted for the generation of p55-specific systemic and mucosal Ab responses.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9164952

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  8 in total

1.  The strength of B cell immunity in female rhesus macaques is controlled by CD8+ T cells under the influence of ovarian steroid hormones.

Authors:  F X Lü; K Abel; Z Ma; T Rourke; D Lu; J Torten; M McChesney; C J Miller
Journal:  Clin Exp Immunol       Date:  2002-04       Impact factor: 4.330

2.  Immunoglobulin concentrations and antigen-specific antibody levels in cervicovaginal lavages of rhesus macaques are influenced by the stage of the menstrual cycle.

Authors:  F X Lü; Z Ma; T Rourke; S Srinivasan; M McChesney; C J Miller
Journal:  Infect Immun       Date:  1999-12       Impact factor: 3.441

3.  Effective induction of simian immunodeficiency virus-specific systemic and mucosal immune responses in primates by vaccination with proviral DNA producing intact but noninfectious virions.

Authors:  S W Wang; P A Kozlowski; G Schmelz; K Manson; M S Wyand; R Glickman; D Montefiori; J D Lifson; R P Johnson; M R Neutra; A Aldovini
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

4.  Enhanced in vivo immunogenicity of SIV vaccine candidates with cationic liposome-DNA complexes in a rhesus macaque pilot study.

Authors:  Jeff Fairman; Joseph Moore; Mathieu Lemieux; Koen Van Rompay; Yongzhi Geng; John Warner; Kristina Abel
Journal:  Hum Vaccin       Date:  2009-03-14

5.  Human immunodeficiency virus type 1 gag-specific mucosal immunity after oral immunization with papillomavirus pseudoviruses encoding gag.

Authors:  Hongtao Zhang; Raja Fayad; Xilin Wang; Daniel Quinn; Liang Qiao
Journal:  J Virol       Date:  2004-10       Impact factor: 5.103

6.  Development of Safe and Non-Self-Immunogenic Mucosal Adjuvant by Recombinant Fusion of Cholera Toxin A1 Subunit with Protein Transduction Domain.

Authors:  Byoung-Shik Shim; In Su Cheon; Eugene Lee; Sung-Moo Park; Youngjoo Choi; Dae-Im Jung; Eunji Yang; Jung-Ah Choi; June Young Chun; Jae-Ouk Kim; Cheol-Heui Yun; Cecil Czerkinsky; Man Ki Song
Journal:  J Immunol Res       Date:  2018-03-07       Impact factor: 4.818

7.  Defense-in-depth by mucosally administered anti-HIV dimeric IgA2 and systemic IgG1 mAbs: complete protection of rhesus monkeys from mucosal SHIV challenge.

Authors:  Anton M Sholukh; Jennifer D Watkins; Hemant K Vyas; Sandeep Gupta; Samir K Lakhashe; Swati Thorat; Mingkui Zhou; Girish Hemashettar; Barbara C Bachler; Donald N Forthal; Francois Villinger; Quentin J Sattentau; Robin A Weiss; Gloria Agatic; Davide Corti; Antonio Lanzavecchia; Jonathan L Heeney; Ruth M Ruprecht
Journal:  Vaccine       Date:  2015-03-11       Impact factor: 3.641

Review 8.  Challenges in mucosal HIV vaccine development: lessons from non-human primate models.

Authors:  Iskra Tuero; Marjorie Robert-Guroff
Journal:  Viruses       Date:  2014-08-15       Impact factor: 5.048

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.